Skip to main content
$87.35 $2.53 (3.0%)

11:12 AM EDT on 07/29/21

Fate Therapeutics (NASDAQ:FATE)

CAPS Rating: 3 out of 5

Current Price $87.35 Mkt Cap $8.0B
Open $85.57 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $84.28 - $88.46 Volume 231,920
52-Wk Range $29.37 - $121.16 Avg. Daily Vol. 987,265

Caps

How do you think NASDAQ:FATE will perform against the market?

Add Stock to CAPS Watchlist

All Players

58 Outperform
4 Underperform
 

All-Star Players

13 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:FATE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:FATE VS S&P 500 (SPY)

NASDAQ:FATE Summary

Fools bullish on NASDAQ:FATE are also bullish on:

Fools bearish on NASDAQ:FATE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about FATE.

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 10/7/2020 12:24:59 PM : Outperform Start Price: $43.59 NASDAQ:FATE Score: +70.65

This company has the world's first platform for producing therapies based on inducible stem cells, opening the door for off-the-shelf solutions in immunotherapy and other key cell therapy domains.

Recs

0
Member Avatar ted368 (< 20) Submitted: 10/6/2020 1:51:34 PM : Outperform Start Price: $41.89 NASDAQ:FATE Score: +79.35

Solid Partner in product and development.

Recs

0
Member Avatar odocoileus (58.70) Submitted: 2/2/2020 6:12:25 PM : Outperform Start Price: $20.02 NASDAQ:FATE Score: +300.34

I admit there was a bit of FOMO going on when I green-thumbed this stock. I think it was the big words that impressed me most. Pluri-potent stem cells. How can you not want to open your wallet and just start dishing it out? While my lack of DD is apparent, I can say that I'm impressed with a couple of things. One is the number of candidates FATE has in the pipeline. The other is that many of these candidates try to attack more than one weakness on a cancer cell. FT596 is a good example. The problem with attacking a single site is that the cell line has a tendency to work around that attack. You may have initial good results, but the surviving cells then produce more cells resistant to that drug. You can use combo therapy or a drug that targets more than one site on the cancer cell. FATE is doing both. I get excited when I see this and tend to green-thumb stuff before I really know enough to make an informed decision. Take that into consideration.

Leaderboard

Find the members with the highest scoring picks in FATE.

Score Leader

stainsolution

stainsolution (68.44) Score: +5,361.82

The Score Leader is the player with the highest score across all their picks in FATE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stainsolution 68.44 2/17/2016 Outperform 5Y $1.57 +5,490.73% +128.91% +5,361.82 0 Comment
oscillation 75.21 2/11/2016 Outperform 5Y $1.72 +5,001.75% +141.76% +4,859.99 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. biznessdoc 66.17 8/15/2016 Outperform 5Y $2.57 +3,304.47% +101.69% +3,202.78 0 Comment
portefeuille2 98.91 8/17/2016 Outperform 5Y $2.65 +3,201.70% +102.51% +3,099.18 0 Comment
shonny2 57.10 2/6/2017 Outperform 5Y $2.87 +2,948.61% +92.90% +2,855.71 0 Comment
NoPlaceLikeHome 77.83 3/9/2017 Outperform 5Y $4.09 +2,041.86% +86.39% +1,955.47 3 Comments
Under5 70.12 11/16/2017 Outperform 5Y $4.40 +1,888.48% +70.63% +1,817.85 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TruffelPig < 20 3/1/2017 Outperform 5Y $4.40 +1,888.52% +85.19% +1,803.33 0 Comment
skellsmother < 20 11/11/2013 Outperform 1Y $4.45 +1,866.18% +149.00% +1,717.18 1 Comment
cyberterrorist < 20 11/12/2013 Outperform 1Y $4.51 +1,840.02% +149.51% +1,690.51 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FATE.